Another meta-analysis of 2,645 glioma cases and 3,920 control subjects, excluding analysis of glioma subtypes, showed no significant association between the TP53 rs1042522 C>G polymorphism and risk of glioma [42]. The gene discussed is TP53; the disease is central nervous system cancer.